Henney on supplements
This article was originally published in The Tan Sheet
Executive Summary
Agency staffers are "trying to bring...to closure as expeditiously as we can" the rulemaking on structure/function claims, FDA Commissioner Jane Henney, MD, states Oct. 21 at the Senate Health & Education Committee hearing on implementation of the FDA Modernization Act. Henney's comment came in response to a query from Sen. Barbara Mikulski (D-Md.) expressing concern over "quackery or exaggerated claims"
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning